Oncology & Hematology Coding Alert

Chemotherapy:

Take a Closer Look at Adverse Reaction Coding

Remember that you don't need two separate diagnoses for chemo plus E/M. "Seize Every Code When Chemotherapy Results in Adverse Reaction" in Oncology and Hematology Coding Alert, vol. 12, no. 2, discussed CMS's view on coding E/M with chemotherapy, as published in MLN Matters article SE0462 (www.cms.gov/MLNMattersArticles/downloads/SE0462.pdf). To be sure you've got the information you need to apply Medicare's rules appropriately, here are some extra pointers to consider before you code. Don't Fret Over Distinct ICD-9 Codes The MLN Matters article states, "If a patient has a significant adverse reaction to drugs during a chemotherapy session and the physician intervenes, the physician can bill for a visit in addition to the chemotherapy administration services." In addition, if the patient had already seen the physician on the same day and develops an adverse reaction during therapy, you may be entitled to a higher-level visit or prolonged services as the article [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more